/Investor DB

SARAS CAPITAL — 2026 Investments

4 investments dated 2026 · listed companies and verified rows first · show all

Biographicagraphica.bioinJan 2026

Graphica applies foundational AI models to precision plant breeding, genetics and molecular biology, building plants and biological products.

AgTechAI & Machine LearningBiotechLondon, GB

Cecy Price(CEO)inDominic Hall(CTO)in

Co-investorsEntrepreneur FirstFaberFaber Capital SCR SAHelmNucleus CapitalSie Ventures+4 more

Convergerunconverge.comin𝕏Jan 2026 · $25M

Converge is an AI-native growth platform for direct-to-consumer brands that automates media buying, attribution analysis, and reporting through agentic AI.

AdTechAI & Machine LearningDirect to ConsumerE-commerceEnterprise SoftwareSaaSNew York City, US

Jan-Henrik Lambrechts(Founder)inJerome Billiet(Founder)inThomas Holvoet(Founder)inJérôme Billiet(Founder)inGideon Farrell(Founder)Raph Scheps(Founder)

Co-investorsEntourage VenturesUncorrelated VenturesY CombinatorBessemer Venture PartnersCambridge Angels groupEMV Capital+7 more

Convergeconverge-bio.cominJan 2026 · $25M

Converge Bio develops generative AI models trained on DNA, RNA, and protein sequences to support drug discovery and development for biotech and pharmaceutical companies.

AI & Machine LearningBiotechDeep TechClaymont, US

Dov Gertz(Founder)inOded Kalev(Founder)inIddo Weiner(Founder)inDov Gertz Oded Kalev(Founder)Iddo Wiener(Founder)

BoardShahar Tzafrir(Director)in

Co-investorsBessemer Venture PartnersICON - Israel Collaboration NetworkTLV PartnersVintage Investment Partners

Convergeconvergeins.cominJan 2026 · $25M

Converge is an insurtech company that underwrites cyber risk insurance, distributing coverage to broker-partners across the U.S. through a capacity partnership with QBE.

AI & Machine LearningCybersecurityFintechInsurTech

Steven Petrevski(Founder)inTom Kang(Chief Executive Officer)Howie Altman(Chief Technology Officer)in

Co-investorsForgePoint CapitalBessemer Venture PartnersTLV PartnersVintage Investment Partners

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.